Page last updated: 2024-12-11
methyl retinoate
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
methyl retinoate: RN given refers to cpd without isomeric designation [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
| ID Source | ID |
|---|---|
| PubMed CID | 5378821 |
| CHEMBL ID | 488005 |
| SCHEMBL ID | 990601 |
| MeSH ID | M0086535 |
Synonyms (30)
| Synonym |
|---|
| ro 4-3781 |
| beta-retinoic acid methyl ester |
| vitamin a acid methyl ester |
| all-trans-methylretinoate |
| vitamin a-saeuremethylester [german] |
| brn 2059353 |
| methyl retinoate |
| retinoic acid, methyl ester, all-trans- |
| retinoic acid, methyl ester |
| CHEMBL488005 |
| retinoic acid methyl ester |
| all-trans-retinoic acid methyl ester |
| retinoic acid, methyl ester, 13-cis- |
| methyl (2e,4e,6e,8e)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenoate |
| ws76i7l4s7 , |
| unii-ws76i7l4s7 |
| 339-16-2 |
| vitamin a-saeuremethylester |
| all-trans retinoic acid methyl ester |
| SCHEMBL990601 |
| all-trans-vitamin a acid methyl ester |
| SREQLAJQLXPNMC-DXYSAURFSA-N |
| .beta.-retinoic acid methyl ester |
| all-trans-methyl retinoate |
| 861043-70-1 |
| methyl all-trans-retinoate |
| J-019374 |
| 11-cis retinoic acid methyl ester |
| Q27292800 |
| DTXSID401316812 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Bioassays (7)
| Assay ID | Title | Year | Journal | Article |
|---|---|---|---|---|
| AID1136170 | Reversal of keratinized lesions in vitamin A deficient hamster tracheal organ culture assessed as cultures with keratin and keratohyaline granules at 10 nM after 7 days (Rvb = 93%) | 1977 | Journal of medicinal chemistry, Jul, Volume: 20, Issue:7 | Dihydroretinoic acids and their derivatives. Synthesis and biological activity. |
| AID1136169 | Reversal of keratinized lesions in vitamin A deficient hamster tracheal organ culture assessed as cultures with keratin and keratohyaline granules at 0.1 uM after 7 days (Rvb = 93%) | 1977 | Journal of medicinal chemistry, Jul, Volume: 20, Issue:7 | Dihydroretinoic acids and their derivatives. Synthesis and biological activity. |
| AID334311 | Induction of morphological transformation of rat ASK cells into astrocytes after 1 hr by light microscopy | |||
| AID1136173 | Increase in RNA content in mouse epidermal cells at 1 uM after 3 days | 1977 | Journal of medicinal chemistry, Jul, Volume: 20, Issue:7 | Dihydroretinoic acids and their derivatives. Synthesis and biological activity. |
| AID1136176 | Increase in RNA content in mouse epidermal cells at 1 nM after 3 days | 1977 | Journal of medicinal chemistry, Jul, Volume: 20, Issue:7 | Dihydroretinoic acids and their derivatives. Synthesis and biological activity. |
| AID1136174 | Increase in RNA content in mouse epidermal cells at 0.1 uM after 3 days | 1977 | Journal of medicinal chemistry, Jul, Volume: 20, Issue:7 | Dihydroretinoic acids and their derivatives. Synthesis and biological activity. |
| AID1136175 | Increase in RNA content in mouse epidermal cells at 10 nM after 3 days | 1977 | Journal of medicinal chemistry, Jul, Volume: 20, Issue:7 | Dihydroretinoic acids and their derivatives. Synthesis and biological activity. |
| [information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||||
Research
Studies (10)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 8 (80.00) | 18.7374 |
| 1990's | 2 (20.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
Market Indicators
Research Demand Index: 11.67
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (11.67) All Compounds (24.57) |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 13 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||